Invus has invested in Autobahn Therapeutics, a biotech group. Invus was one of 11 investors committing $32.7 million to the San Diego-based group.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in
